Brief: India's Suven Pharmaceuticals Ltd Sept-Quarter Consol Net Profit Rises
Nov 9 (Reuters) - Suven Pharmaceuticals Ltd SUVH.NS :
* INDIA'S SUVEN PHARMACEUTICALS LTD SEPT-QUARTER CONSOL NET
PROFIT
795.6 MILLION RUPEES VERSUS 720.6 MILLION RUPEES YEAR AGO
* SUVEN PHARMACEUTICALS LTD SEPT-QUARTER CONSOL REVENUE FROM
OPERATIONS 2.31 BILLION RUPEES VERSUS 2.78 BILLION RUPEES YEAR
AGO
Source text for Eikon: ID:
Further company coverage: SUVH.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cohance Lifesciences
See all newsBrief: Cohance Lifesciences Names Abhimanyu Ojha As CFO
Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
India's Cohance Lifesciences falls after US FDA inspection at Telangana plant
Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
India's Cohance Lifesciences climbs on second-half growth outlook despite Q1 loss